Clinical implementation of intensity modulated proton therapy for testicular seminoma
We have established a robust setup for treatment planning, IG strategy, treatment delivery and adequate response to replanning. Therefore, we suggest considering IMPT for testicular seminoma whenever available.
Authors
- Anne Birgitte Als
- Heidi S. Rønde (ORCID: https://orcid.org/0000-0002-2736-8433)
- Jesper Folsted Kallehauge (ORCID: https://orcid.org/0000-0003-3705-5390)
- Jakob Lauritsen (ORCID: https://orcid.org/0000-0002-9985-174X)
- Peter Nørgaard Petersen (ORCID: https://orcid.org/0000-0002-2682-023X)
- Lars Dysager
- Mads Agerbæk (ORCID: https://orcid.org/0000-0003-3923-6136)
- Camilla Kronborg (ORCID: https://orcid.org/0000-0001-9783-4340)
- Morten Høyer (ORCID: https://orcid.org/0000-0001-8609-0008)
Institutions
- Odense University Hospital (DK)
- Aarhus University Hospital (DK)
- Rigshospitalet (DK)
- Danish Pain Research Center (DK)
Publication Details
- Journal
- Acta Oncologica
- Published
- 2025-09-25
- DOI
- https://doi.org/10.2340/1651-226x.2025.43848
- Primary Topic
- Testicular diseases and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00